Fredun Pharmaceuticals Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Fredun Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
32.77% Fall from 52W High
-3.8
TTM PE Ratio
Below industry Median
25.1
Price to Book Ratio
Below industry Median
3.2
Dividend yield 1yr %
Low in industry
0.1
TTM PEG Ratio
PEG TTM is less than 1
0.7
RSI
RSI is mid-range
47.5
MFI
MFI is mid-range
47

Fredun Pharmaceuticals Ltd shareholding Pattern

Promoter
49.2%
Public
49.2%
Promoter
49.2%
Public
49.2%
Promoter
49.3%
Public
49.1%
Promoter
49.6%
Public
48.7%
Promoter
50.2%
Public
48.2%
Promoter
50.3%
Public
48%
Foreign Institutions
0.9%
Foreign Institutions
1.2%
Foreign Institutions
1.2%
Foreign Institutions
1.2%
Foreign Institutions
1.7%
Mutual Funds
3.2%
Mutual Funds
3.2%

Fredun Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
849.70
10Day EMA
858.40
12Day EMA
860.20
20Day EMA
860.10
26Day EMA
856.80
50Day EMA
846.30
100Day EMA
846.00
200Day EMA
864.00
5Day SMA
851.30
10Day SMA
857.00
20Day SMA
884.60
30Day SMA
854.90
50Day SMA
819.30
100Day SMA
837.40
150Day SMA
847.20
200Day SMA
872.20
Delivery & Volume
Resistance & Support
842.77
Pivot
Resistance
First Resistance
855.13
Second Resistance
870.62
Third Resistance
882.98
Support
First Support
827.28
Second support
814.92
Third Support
799.43
Relative Strength Index
47.50
Money Flow Index
47.05
MACD
3.41
MACD Signal
11.71
Average True Range
51.19
Average Directional Index
12.78
Rate of Change (21)
1.81
Rate of Change (125)
-2.39
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Lyka Labs Ltd.
363.16
89
143.5
Venus Remedies Ltd.
396.73
194.95
429.6
Wanbury Ltd.
483.98
41.2
177.4
Ambalal Sarabhai Enterprises Ltd.
-
-
-
Shukra Pharmaceuticals Ltd.
-
-
-
Zenotech Laboratories Ltd.
-
-
-
Fredun Pharmaceuticals Ltd.
-
-
-

Fredun Pharmaceuticals Ltd Company background

Founded in: 1987
Managing director: Daulat N Medhora
Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharmas operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The Company has an unique range of products, from niche formulations , antidiabetics to the latest antiretroviral and anti Hypertensive products. It supplies finished formulations to over 42 Countries globally. It is associated with many Governments of different countries which have also realised the need for robust and consistent healthcare systems.The Company was set up with the objective of providing facilities for manufacturing and marketing of various pharmaceutical formulations like tablets, capsules, drysyrups and ointments. It then set up a formulation unit at Palghar (Thane District), Maharashtra, which commenced commercial production in Aug.94. FPL had been carrying out manufacturing operations on loan licence for reputed pharmaceutical companies like Cipla. It also manufactured for some merchant exporters, including Merind.In Apr.96, the company came out with a public issue to register its products in the overseas market for exports to partfinance the expansion of its business activities and to repay one of the term loans and unsecured loans to reduce the interest burden. Company is very much optimistic of revival of companys turnover by having excellent export order in hand. Company also in process of registering various drugs with different countires such as Nepal, Tanzaniya, Uganda Sri Lanka.In 2013, Company launched 36 new products and filed 60 new products for registration. It launched a herbal dietary supplement in Africa. During 2015, three new granulation departments were introduced to the existing two departments. It launched 19 new products under the Cosmeceuticals OEM Division in 2023. It introduced 14 new products in the pet pharmaceuticals line, with another 36 in the works. It launched 16 products into the Pet Treat and Nutritional Supplement category.
Read More

Fredun Pharmaceuticals Ltd FAQs

You can easily buy Fredun Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage